Updated:
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001311596, and its reported...
Overview
Tobira Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001311596, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2016-03-03, it reported net income of USD -49,617,000; total assets of USD 65,469,000 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Tobira Therapeutics, Inc.
- Former names in filing history
- Tibira Therapeutics, Inc. (2015-05-06 to 2015-05-06); Regado Biosciences Inc (2004-12-08 to 2015-05-06)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001311596
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2015USD | -$49.6M | $65.5M | $62.4M | — | |
| FY2014USD | -$67.1M | $54.4M | $51.6M | -$52.7M | |
| FY2013USD | -$34.4M | $45.8M | $30.7M | -$34.7M |
FY2015. Total assets: shown as originally filed; later filings report different values for the same periods.
FY2014. Net income, Total assets, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
FY2013. Net income, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| SC 13D | — | SC 13D | |
| SC 13G | — | Form SC 13G | |
| SC 13G | — | PENTWATER CAPITAL MANAGEMENT LP SC 13G 9-20-2016 (TOBIRA THERAPEUTICS, INC) | |
| 8-K | 8-K | ||
| 10-Q | TBRA-Q2-20160630 | ||
| 8-K | Q2 2016 EARNINGS 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Tobira Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.